Beta-blockade in heart failure: A comparison of carvedilol with metoprolol

Journal of the American College of Cardiology

Volumn 34, Issue 5, 1999, Pages 1522-1528

  Sanderson, John E ^a   Chan, Skiva K W ^a   Yip, Gabriel ^a   Yeung, Leata Y C ^a   Chan, Kam W ^a   Raymond, Kenneth ^a   Woo, Kam S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; METOPROLOL;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SELECTIVITY; DRUG TOLERABILITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE SIZE; HEART RATE VARIABILITY; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RADIOISOTOPE VENTRICULOGRAPHY; RANDOMIZED CONTROLLED TRIAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CARBAZOLES; DOUBLE-BLIND METHOD; EXERCISE TEST; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; METOPROLOL; MIDDLE AGED; PROPANOLAMINES; PROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 0033230514     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00367-8     Document Type: Article

References (29)

1. Lechat P., Packer M., Chalon S., et al. Clinical effects of β-adrenergic blockade in chronic heart failure. A meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation. 98:1998;1184-1191.
2. Cleland J.G.F., Bristow E.E., Remmes W.J., et al. Beta blocking agents in heart failure. Should they be used? Eur Heart J. 17:1996;1629-1639.
3. Waagstein F., Hjalmarson A., Varnauskass E., Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 37:1975;1022-1026.
4. Swedberg K., Hjalmarson A., Waagstein F., Wallentin I. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet. i:1979;1364-1366.
5. Waagstein F., Bristow M.R., Swedberg K., et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet. 342:1993;1441-1446.
6. Eichhorn E.J., Heesch C.M., Barnett J.H., et al. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy a randomized, double-blind, placebo-controlled study . J Am Coll Cardiol. 24:1994;1310-1320.
7. Sanderson J.E., Chan S.K.W., Yu C.M., et al. β-Blockers in heart failure a comparison of a vasodilating β-blocker with metoprolol . Heart. 79:1998;86-92.
8. MOCHA investigators , Bristow M., Gilbert E.M., Abraham W.T., et al. Carvedilol produces dose-related improvements in LV function and survival in subjects with chronic heart failure. Circulation. 94:1996;2807-2816.
9. PRECISE Study Group , Packer M., Colucci W., Sackner-Bernstein J.D., et al. Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. Circulation. 94:1996;2793-2799.
10. US Carvedilol Heart Failure Study Group , Colucci W.S., Packer M., Bristow M.R., et al. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. Circulation. 94:1996;2800-2806.
11. US Carvedilol Heart Failure Study Group , Packer M., Bristow M.R., Cohn J., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 334:1996;1349-1355.
12. Frishman W.H. Carvedilol. N Engl J Med. 339:1998;1759-1765.
13. Cohen G.I., Pietrolungo J.F., Thomas J.D., Klein Al. A practical guide to assessment of ventricular diastolic function using Doppler echocardiography. J Am Coll Cardiol. 27:1996;1753-1760.
14. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology . Heart Rate Variability. Standards of Measurement, Physiological Interpretation, and Clinical Use. Circulation. 93:1996;1043-1065.
15. Yusuf S., Tsuyuki R. Using exercise endpoints in heart failure trials design considerations . Eur Heart J. 17:1996;4-6.
16. Gilbert E.M., Abraham W.T., Olsen S., et al. Comparative hemodynamic, LV functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation. 94:1996;2817-2825.
17. Kukin M.L., Kalman J., Mannino M., et al. Combined alpha-beta blockade (doxazosin plus metoprolol) compared with beta blockade alone in chronic congestive heart failure. Am J Cardiol. 77:1996;486-491.
18. Weber K., Bohmeke T., van der Does R., Taylor S.H. Hemodynamic differences between metoprolol and carvedilol in hypertensive patients. Am J Hypertension. 11:1998;614-617.
19. Andersson B., Caidahl K., di Lenarda A., et al. Changes in early and late diastolic filling patterns induced by long-term adrenergic β-blockade in patients with idiopathic dilated cardiomyopathy. Circulation. 94:1996;673-682.
20. Quaife R.A., Gilbert E.M., Christian P.E., et al. Effect of carvedilol on systolic and diastolic LV performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy. Am J Cardiol. 78:1996;779-784.
21. Yu C.M., Sanderson J.E. Right and LV diastolic function in patients with and without heart failure effect of age, sex, heart rate, and respiration on Doppler-derived measurements . Am Heart J. 134:1997;426-434.
22. Garcia M.J., Thomas J.D., Klein A.L. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol. 32:1998;865-875.
23. Yu H.C.M., Sanderson J.E. Different prognostic significance of right and LV diastolic dysfunction in heart failure. Clin Cardiol. 22:1999;504-512.
24. Xie G.Y., Berk M.R., Smith M.D., et al. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol. 24:1994;132-139.
25. Rihal C.S., Nishimura R.A., Hatle L.K., et al. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis. Circulation. 90:1994;2772-2779.
26. Little W.C., Ohno M., Kitzman D.W., et al. Determination of LV chamber stiffness from the time of deceleration of early ventricular filling. Circulation. 92:1995;1933-1939.
27. O'Callaghan C.J., Williams B. Adrenergic stimulation increases extracellular matrix production by human vascular smooth muscle cells the role of TGFβ J Hypertension. 16:(Suppl 2):1998;61.
28. Sanderson J.E., Yeung L.Y., Chan S., et al. Effect of β-blockade on baroreceptor and autonomic function in heart failure. Clin Science. 96:1999;137-146.
29. Nolan J., Batin P.D., Andrews R., et al. Prospective study of heart rate variability and mortality in chronic heart failure. Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart). Circulation. 98:1998;1510-1516.